China National Accord Medicines Corporation Ltd. (SHE:200028)

Market Cap	13.68B +1.8%
Revenue (ttm)	73.42B -1.3%
Net Income	1.14B +76.8%
EPS	2.04 +77.4%
Shares Out	n/a
PE Ratio	12.04
Forward PE	10.55
Dividend	0.37 (2.66%)
Ex-Dividend Date	Jun 25, 2025

Volume	216,030
Average Volume	197,771
Open	13.73
Previous Close	13.95
Day's Range	13.70 - 13.95
52-Week Range	10.15 - 14.09
Beta	0.31
RSI	60.53
Earnings Date	Apr 2, 2026

About SHE:200028

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources through retail and medical service stores, as well as chemical drugs, OTC dr...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1993
• Employees: 39,449
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 200028

Financial Performance

In 2025, SHE:200028's revenue was 73.42 billion, a decrease of -1.29% compared to the previous year's 74.38 billion. Earnings were 1.14 billion, an increase of 76.80%.